))
5: Inclisiran - Cardiovascular Disease Prevention and Lipid Management
Manage episode 352334642 series 2945603
Το περιεχόμενο παρέχεται από το Innovation in Healthcare. Όλο το περιεχόμενο podcast, συμπεριλαμβανομένων των επεισοδίων, των γραφικών και των περιγραφών podcast, μεταφορτώνεται και παρέχεται απευθείας από τον Innovation in Healthcare ή τον συνεργάτη της πλατφόρμας podcast. Εάν πιστεύετε ότι κάποιος χρησιμοποιεί το έργο σας που προστατεύεται από πνευματικά δικαιώματα χωρίς την άδειά σας, μπορείτε να ακολουθήσετε τη διαδικασία που περιγράφεται εδώ https://el.player.fm/legal.
The Academic Health Science Network North East North Cumbria delivers a national programme of work looking at cholesterol and lipid optimisation.
Recently, a number of new non-statin treatments that have been made available on the lipid pathway, which will help patients to reduce their cholesterol, and therefore reduce heart attacks and strokes.
Inclisiran is one of these new therapies, but what's really important is the way it has been delivered, taking a population health management approach, meaning that patients can access treatment much more quickly as it is rolled out through primary care.
This is a world-first and an exciting time to be involved in lipid management.
In this podcast, CVD Prevention Lead and Regional Coordinator, Nikki Holdsworth, talks to Barry Todd - a North East Pharmacist Practitioner and Wallsend Pharmacy Lead, and Matthew Hart - a Specialist Clinical Pharmacist with The Newcastle Upon Tyne Hospitals Trust, who are involved in lipid optimisation and management, and have experience of initiating and managing patients on one of these new therapies, Inclisiran.
Find out more about Inclisiran
Learn more about the Lipid Management Pathway
Recently, a number of new non-statin treatments that have been made available on the lipid pathway, which will help patients to reduce their cholesterol, and therefore reduce heart attacks and strokes.
Inclisiran is one of these new therapies, but what's really important is the way it has been delivered, taking a population health management approach, meaning that patients can access treatment much more quickly as it is rolled out through primary care.
This is a world-first and an exciting time to be involved in lipid management.
In this podcast, CVD Prevention Lead and Regional Coordinator, Nikki Holdsworth, talks to Barry Todd - a North East Pharmacist Practitioner and Wallsend Pharmacy Lead, and Matthew Hart - a Specialist Clinical Pharmacist with The Newcastle Upon Tyne Hospitals Trust, who are involved in lipid optimisation and management, and have experience of initiating and managing patients on one of these new therapies, Inclisiran.
Find out more about Inclisiran
Learn more about the Lipid Management Pathway
8 επεισόδια
Μοίρασέ το
